Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series
Author:
Sherman Amy C.ORCID,
van Haren Simon D.,
Borberg Ella,
Swank Zoe,
Aleissa Muneerah,
Tong Alexandra,
Rooks Rebecca,
Kanwal Urwah,
Levine Hannah,
Yates Bridget,
Izaguirre Natalie,
Ryff Kevin,
Thomas Sanya,
Parisi Lindsey,
Li Xiaofang,
Walt David R.,
Levy Ofer,
Walsh Stephen R.,
Issa Nicolas C.,
Baden Lindsey R.